INTERPHARM LAB LTD has a total of 45 patent applications. Its first patent ever was published in 1986. It filed its patents most often in EPO (European Patent Office), Israel and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are CATALENT PHARMA SOLUTIONS LLC, PLANET BIOTECHNOLOGY INC and XCYTE THERAPIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | Israel | 9 | |
#3 | Australia | 7 | |
#4 | Canada | 4 | |
#5 | United States | 4 | |
#6 | South Africa | 4 | |
#7 | Japan | 3 | |
#8 | WIPO (World Intellectual Property Organization) | 3 | |
#9 | Cyprus | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Machines | |
#5 | Engines, pumps and turbines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes | |
#6 | Unspecified technologies | |
#7 | Microbiology | |
#8 | Internal-combustion piston engines |
# | Name | Total Patents |
---|---|---|
#1 | Draghi Enrica | 5 |
#2 | Mory Yves | 5 |
#3 | Fischer Dina | 5 |
#4 | Michalevicz Rita | 5 |
#5 | Bracha Moshe | 5 |
#6 | Messika Ziva | 4 |
#7 | Moav Neomi | 4 |
#8 | Chitlaru Edith | 4 |
#9 | Amitai Hagit | 4 |
#10 | Harel Adrian | 4 |
Publication | Filing date | Title |
---|---|---|
IL126562D0 | Expression and secretion of icil-1 receptor antagonist type ii | |
IL133283D0 | Preparation of glycosylated tumor necrosis factor | |
IL120979D0 | Glycosylated TNF | |
EP0863990A1 | Use of anti-sense sequences to increase responsiveness to gene amplification | |
ZA9509429B | Use of anti-sense sequences to increase responsiveness to gene amplification | |
IL111211D0 | Gene expression system | |
IL106106D0 | Library of polymeric molecules and its preparation | |
IL102929D0 | Serum-free medium for mammalian cells | |
IL101792D0 | Bioreactor and basket therefor | |
EP0643973A1 | Use of human interferon-beta for the preparation of pharmaceutical compositions for treating Chronic Myeloid Leukemia | |
IL79950D0 | Anti-trichomonas vaginalis mono-trichomonas clonal antibodies inducing complement-dependent cytotoxicity,their use in immunotherapy and immunodiagnosis |